Connection

Announcement

You can now add alternative names! Click here to add other names that you've published under.

Search Results to Michael Birrer

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Birrer, Michael

One or more keywords matched the following items that are connected to Birrer, Michael

Item Type	Name
Academic Article	Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers.
Concept	Neoplasm Staging
Academic Article	GOG 8020/210: Risk stratification of lymph node metastasis, disease progression and survival using single nucleotide polymorphisms in endometrial cancer: An NRG oncology/gynecologic oncology group study.
Academic Article	Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer.
Academic Article	Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence.
Academic Article	Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.
Academic Article	Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
Academic Article	Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Academic Article	Better therapeutic trials in ovarian cancer.
Academic Article	Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome.
Academic Article	Dicer, Drosha, and outcomes in patients with ovarian cancer.
Academic Article	Validation of serum biomarkers for detection of early-stage ovarian cancer.
Academic Article	BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Academic Article	Extended carboplatin infusion does not reduce frequency of hypersensitivity reaction at initiation of retreatment in patients with recurrent platinum-sensitive ovarian cancer.
Academic Article	Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma.
Academic Article	Outcomes of Women With High-Grade and Low-Grade Advanced-Stage Serous Epithelial Ovarian Cancer.
Academic Article	Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival.
Academic Article	Whole genome oligonucleotide-based array comparative genomic hybridization analysis identified fibroblast growth factor 1 as a prognostic marker for advanced-stage serous ovarian adenocarcinomas.
Academic Article	Up-regulation of stromal versican expression in advanced stage serous ovarian cancer.
Academic Article	High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.
Academic Article	An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
Academic Article	Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.
Academic Article	Clusterin interacts with Paclitaxel and confer Paclitaxel resistance in ovarian cancer.
Academic Article	Comparative meta-analysis of prognostic gene signatures for late-stage ovarian cancer.
Academic Article	Risk prediction for late-stage ovarian cancer by meta-analysis of 1525 patient samples.
Academic Article	Phase I Study of MEDI3617, a Selective Angiopoietin-2 Inhibitor Alone and Combined with Carboplatin/Paclitaxel, Paclitaxel, or Bevacizumab for Advanced Solid Tumors.
Academic Article	Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: a Gynecologic Oncology Group study.
Academic Article	EMR 20006-012: A phase II randomized double-blind placebo controlled trial comparing the combination of pimasertib (MEK inhibitor) with SAR245409 (PI3K inhibitor) to pimasertib alone in patients with previously treated unresectable borderline or low grade ovarian cancer.
Academic Article	Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group study.
Academic Article	Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer.
Academic Article	Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.
Academic Article	Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-beta signaling in ovarian cancer.
Academic Article	Uterine papillary serous cancer: a review of the literature.
Academic Article	Clinicopathological analysis of c-kit expression in carcinosarcomas and leiomyosarcomas of the uterine corpus.
Academic Article	Identification of FGFR4 as a potential therapeutic target for advanced-stage, high-grade serous ovarian cancer.
Academic Article	Nuclear P27 expression in benign, borderline (LMP) and invasive tumors of the ovary and its association with prognosis: a gynecologic oncology group study.
Academic Article	Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways.
Academic Article	Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
Academic Article	Age-specific survival of women with endometrioid adenocarcinoma of the uterus.
Academic Article	The role of p27 in endometrial carcinoma.
Academic Article	BRCA1 expression and improved survival in ovarian cancer patients treated with intraperitoneal cisplatin and paclitaxel: a Gynecologic Oncology Group Study.
Academic Article	Sex Hormones, Insulin, and Insulin-like Growth Factors in Recurrence of High-Stage Endometrial Cancer.
Academic Article	Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study.

Search Criteria

Neoplasm Staging